Nitric oxide in respiratory diseases

Pharmacology and Therapeutics

Volumn 95, Issue 3, 2002, Pages 259-293

  Nevin, B J ^a   Broadley, K J ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Asthma; COPD; Cystic fibrosis; Nitric oxide; NO donors; NOS inhibitors

Indexed keywords

3 (3 CHLORO 2 METHYLPHENYL) 5 (4 METHYLBENZENESULFONYLIMINO) 1,2,3,4 OXATRIAZOLE; ARGININE; BECLOMETASONE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; EBSELEN; FLUTICASONE; GLYCERYL TRINITRATE; HISTAMINE; ISOSORBIDE DINITRATE; LINSIDOMINE; N(G) METHYLARGININE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE DONOR; S NITROSOTHIOL; THIOL DERIVATIVE;

ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYSTIC FIBROSIS; DRUG EFFECT; HUMAN; LUNG; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE;

EID: 0036710032     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-7258(02)00262-0     Document Type: Review

References (395)

1. Abu-Soud H., Hazen S.L. Nitric oxide is a physiological substrate for mammalian peroxidases. J Biol Chem. 275:2000;37524-37532.
2. Abu-Soud H.M., Khassawneh M.Y., Sohn J.T., Murray P., Haxhiu M.A., Hazen S.L. Peroxidases inhibit nitric oxide (NO) dependent bronchodilation: development of a model describing NO-peroxidase interactions. Biochemistry. 40:2001;11866-11875.
3. Adler K.B., Fischer B.M., Li H., Hoon Choe N., Wright D.T. Hypersecretion of mucin in response to inflammatory mediators by guinea pig tracheal epithelial cells in vitro is blocked by inhibition of nitric oxide synthase. Am J Respir Cell Mol Biol. 13:1995;526-530.
4. Agusti A.G.N., Villaverde J.M., Togores B. Serial measurements of exhaled nitric oxide during exacerbations of chronic obstructive pulmonary disease. Eur Resp J. 14:1999;523-528.
5. Aizawa H. Role of nitric oxide in airway inflammation and hyperresponsiveness in bronchial asthma. Allergol Int. 48:1999;25-30.
6. Al-Ali M.K., Howarth P.H. Exhaled nitric oxide levels in exacerbations of asthma, chronic obstructive pulmonary disease and pneumonia. Saudi Med J. 22:2001;249-253.
7. Alving K., Weitzberg E., Lundberg J.M. Increased amount of nitric oxide in exhaled air of asthmatics. Eur Respir J. 6:1993;1368-1370.
8. Alving K., Lundberg J.O.N., Nordvall S.L. Dose-dependent reduction of exhaled nitric oxide in asthmatic children by inhaled steroids. Am J Respir Crit Care Med. 151:1995;A126.
9. Anderson M.P., Sheppard D.N., Berger H.A., Welsh M.J. Chloride channels in the apical membrane of normal and cystic fibrosis and intestinal epithelia. Am J Physiol. 263:1992;L1-L14.
10. Ansarin K., Chatkin J.M., Ferreira I.M., Gutierrez C.A., Zamel N., Chapman K.R. Exhaled nitric oxide in chronic obstructive pulmonary disease: relationship to pulmonary function. Eur Respir J. 17:2001;934-938.
11. Archer S.L., Rist K., Nelson D.P., DeMaster E.G., Cowan N., Weir K. Comparison of the hemodynamic effects of nitric oxide and endothelium-dependent vasodilators in intact lungs. J Appl Physiol. 68:1990;735-747.
12. Archer S.L., Huang J.M.C., Hampl V., Nelson D.P., Schultz P.J., Weir K.J., Weir K. Nitric oxide and cGMP cause vasorelaxation by activation of a charybdotoxin-sensitive K channel by cGMP-dependent protein kinase. Proc Natl Acad Sci USA. 91:1994;7583-7587.
13. Asano K., Chee B.E., Gaston B., Lilly C.M., Craig G., Drazen J.M., Stamler J.S. Constitutive and inducible nitric synthase gene expression, regulation and activity in human lung epithelial cells. Proc Natl Acad Sci USA. 91:1994;10089-10093.
14. Ashutosh K. Nitric oxide and asthma: a review. Curr Opin Pulm Med. 6:2000;21-25.
15. Ashutosh K., Phadke K., Jackson J.F., Steele D. Use of nitric oxide inhalation in chronic obstructive pulmonary disease. Thorax. 55:2000;109-113.
16. Atzori L., Cannas E., Dettori T., Dore M., Severino C., Rosetti L., Congiu L., Montaldo C. Levels of nitrite/nitrate and total thiols in plasma of COPD and chronic respiratory insufficiency patients. Eur Respir J. 10(suppl. 25):1997;477S.
17. Aviado D.M., Kishimoto T., Kneidinger H.J. Bronchopulmonary effects of pentaerthrityl tetranitrate and isoproterenol. J Pharmacol Exp Ther. 165:1969;275-278.
18. Bai T.R., Bramley A.M. Effect of an inhibitor of nitric oxide synthase on neural relaxation of human bronchi. Am J Physiol. 264:1993;L425-L430.
19. Baigorri F., Joseph D., Artigas A., Blanch L. Inhaled nitric oxide does not improve cardiac or pulmonary function in patients with an exacerbation of chronic obstructive pulmonary disease. Crit Care Med. 27:1999;2153-2158.
20. Balfour-Lynn I.M., Laverty A., Dinwiddie R. Reduced upper airway nitric oxide in cystic fibrosis. Arch Dis Child. 75:1996;319-322.
21. Balint B., Kharitonov S.A., Hanazawa T., Donnelly L.E., Shah P.L., Hodson M.E., Barnes P.J. Increased nitrotyrosine in exhaled breath condensate in cystic fibrosis. Eur Respir J. 17:2001;1201-1207.
22. Bannenberg G., Xue J., Engman L., Cotgreave I., Moldeus P., Ryrfeldt A. Characterization of bronchodilator effects of S-nitrosothiois in the isolated perfused and ventilated guinea pig lung. J Pharmac Exp Ther. 272:1995;1238-1245.
23. Baraldi E., Azzolin N.M., Zanconato S., Dario C., Zacchello F. Corticosteroids decrease exhaled nitric oxide in children with acute asthma. J Pediatr. 131:1997;381-385.
24. Baraldi E., Carra S., Dario C., Azzolin N., Ongaro R., Marcer G., Zacchello F. Effect of natural grass pollen exposure on exhaled nitric oxide in asthmatic children. Am J Respir Crit Care Med. 159:1999;262-266.
25. Barnes P.J. Airway neuropeptides and asthma. Trends Pharmacol Sci. 8:1987;24-27.
26. Barnes P.J. Nitric oxide and airways. Eur Respir J. 6:1993;163-165.
27. Barnes P.J. NO or no NO in asthma? Thorax. 51:1996;218-220.
28. Barnes P.J., Adcock I.M. NF-κB: a pivotal role in asthma and a new target for therapy. Trends Pharmacol Sci. 18:1997;46-50.
29. Barnes P.J., Liew F.Y. Nitric oxide and asthmatic inflammation. Immunol Today. 16:1995;128-130.
30. Beauvais F., Joly F. Effects of nitric oxide on the eosinophil survival in vivo. A role for nitrosyl-heme. FEBS Lett. 443:1999;37-40.
31. Beauvais F., Michel L., Dubertret L. The nitric oxide donors, azide and hydroxylamine, inhibit the programmed cell death of cytokine-deprived human eosinophils. FEBS Lett. 361:1995;229-232.
32. Beckman J.S., Koppenol W.H. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and the ugly. Am J Physiol. 271:1996;C1424-C1437.
33. Belvisi M.G., Stretton D., Barnes P. Nitric oxide is the endogenous modulator of cholinergic neurotransmission in guinea pig airways. Eur J Pharmacol. 198:1991;219-221.
34. Belvisi M.G., Stretton C.D., Miura M., Verleden G.M., Tadjkarimi S., Yacoub M.H., Barnes P.J. Inhibitory NANC nerves in human tracheal smooth muscle: a quest for the neurotransmitter. J Appl Physiol. 73:1992;2505-2510.
35. Belvisi M.G., Stretton C.D., Yacoub M., Barnes P.J. Nitric oxide is the endogenous neurotransmitter of bronchodilator nerves in humans. Eur J Pharmacol. 210:1992;221-222.
36. Belvisi M.G., Miura M., Stretton D., Barnes P.J. Endogenous vasoactive intestinal peptide and nitric oxide modulate cholinergic neuotransmission in guinea pig trachea. Eur J Pharmacol. 231:1993;97-102.
37. Belvisi M., Barnes P.J., Larkin S., Yacoub M., Tadjkarimi S., Williams T.J., Mitchell J.A. Nitric oxide synthase activity is elevated in inflammatory lung disease in humans. Eur J Pharmacol. 283:1995;255-258.
38. Belvisi M.G., Ward J.K., Mitchell J.A., Barnes P.J. Nitric oxide as a neurotransmitter in human airways. Arch Int Pharmaocodyn. 329:1995;97-110.
39. Berlyne G., Barnes N. No role for NO in asthma? Lancet. 355:2000;1029-1030.
40. Bernareggi M., Cremona G. Measurement of exhaled nitric oxide in humans and animals. Pulm Pharmacol Ther. 12:1999;331-352.
41. Bernareggi M., Mitchell J.A., Barnes P.J., Belvisi M.G. Dual action of nitric oxide on airway plasma leakage. Am J Respir Crit Care Med. 155:1997;869-874.
42. Birrell M.A., Battram C.H., Haddad E.B., McCluskie K., Bohme G.A., Webber S.E., Foster M.L., Belvisi M.G. The role of inducible nitric oxide synthase in sephadex-induced airway inflammation in the rat. Br J Pharmacol. 129:2000;. 225P.
43. Bloomfield G.L., Sweeney L.B., Fisher B.J., Blocher C.R., Sholley M.M., Sugerman H.J., Fowler A.A. Delayed administration of inhaled nitric oxide preserves alveolar-capillary membrane integrity in porcine gram-negative sepsis. Arch Surg. 132:1997;65-75.
44. Blough N.V., Zafiriou O.C. Reaction of superoxide with nitric oxide to form peroxynitrite in alkaline aqueous solution. Inorg Chem. 24:1985;3502-3504.
45. Bolotina V.M., Najbi S., Palacino J.J., Pagano P.J., Cohen R.A. Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature. 368:1994;850-853.
46. Brave S.R., Hobbs A.J., Gibson A., Tucker J.F. The influence of L-N-nitro-arginine on field stimulation induced contractions and acetylcholine release in guinea pig isolated tracheal smooth muscle. Biochem Biophys Res Commun. 179:1991;1017-1022.
47. Bredenbroker D., Dyarmand D., Meingast U., Fehmann H.C., Staats P., Von Wichert P., Wagern U. Effects of the nitric oxide/cGMP system compared with the cAMP system on airway mucus secretion in the rat. Eur J Pharmacol. 411:2001;319-325.
48. Bredt D.S., Hwang P.M., Synder S.H. Localization of nitric oxide synthase indicating a neuronal role for nitric oxide. Nature. 347:1990;768-770.
49. Buga G.M., Gold M.E., Wood K.S., Chaudhuri G., Ignarro L.J. Endothelium-derived nitric oxide relaxes nonvascular smooth muscle. Eur J Pharmacol. 161:1989;61-72.
50. Burke C., Power C.K., Norris A., Condez A., Schmekel B., Poulter L.W. Lung function and immunopathological changes after inhaled corticosteroid therapy in asthma. Eur Respir J. 5:1992;73-79.
51. Burke-Wolin T., Marsui K., Wolin M.S., Gurtner C.H. Epithelium dependent nitric oxide production by bovine airways. Am Rev Respir Dis. 145:1992;A400.
52. Busse R., Mulsch A. Calcium dependent nitric oxide synthase in endothelial cystol is mediated by calmodulin. FEBS Lett. 265:1990;133-136.
53. Byrick R.J., Hobbs E.G., Martineau R., Noble W.H. Nitroglycerin relaxes large airways. Anesth Analg. 62:1983;421-425.
54. Calhoun W.J., Reed H.E., Moest D.R., Stevens C.A. Enhanced superoxide production by alveolar macrophages and air-space cells, airway inflammation, and alveolar macrophage density changes after segmental antigen bronchoprovocation in allergic subjects. Am Rev Respir Dis. 145:1992;317-325.
55. Carvajal J.A., Germain A.M., Huidobro-Toro J.P., Weiner C.P. Molecular mechanism of cGMP-mediated smooth muscle relaxation. J Cell Physiol. 184:2000;409-420.
56. Chabot F., Mitchell J.A., Quinlan G.J., Evans T.W. Characterization of the vasodilator properties of peroxynitrite on rat pulmonary artery: role of poly (adenosine 5′-diphosphoribose) synthase. Br J Pharmacol. 121:1997;485-490.
57. Chollet-Martin S., Gatecel C., Kermarrec N., Gougerot-Pocidalo M.A., Payen D.M. Alveolar neutrophil functions and cytokine levels in patients with the Adult Respiratory Distress Syndrome during nitric oxide inhalation. Am J Respir Crit Care Med. 153:1996;985-990.
58. Chung K.F. Role of inflammation in the hyperreactivity of the airways in asthma. Thorax. 41:1986;657-662.
59. Clancy R.M., Leszczynska-Piziaka J., Abramson S.B. Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil superoxide anion production via a direct action on the NADPH oxidase. J Clin Invest. 90:1992;1116-1121.
60. Coleman J.W. Nitric oxide in immunity and inflammation. Int Immunopharmacol. 1:2001;1397-1406.
61. Comhair S.A.A., Bhathena P.R., Dweik R.A., Kavuru M., Erzurum S.C. Rapid loss of superoxide dismutase activity during antigen-induced asthmatic response. Lancet. 355:2000;624.
62. Conran N., Ferreira H.H.A., Lorand-Metze I., Thomazzi S.M., Antunes E., de Nucci G. Nitric oxide regulates eosinophil adhesion mechanisms in vitro by changing integrin expression and activity on the eosinophil cell surface. Br J Pharmacol. 134:2001;632-638.
63. Corbel M., Germain N., Boichot E., Burgaud J.L., Lagente V. Anti-inflammatory effects of NCX-950, a nitric oxide releasing derivative of salbutamol, in lipopolysaccharide (LPS)-induced acute lung injury in mice. Inflamm Res. 50(suppl. 3):2001;S204.
64. Corradi M., Majori M., Cacciani G.C., Consigli G.F., De Munari E., Pesci A. Increased exhaled nitric oxide in patients with stable chronic obstructive pulmonary disease. Thorax. 54:1999;572-575.
65. Corradi M., Montuschi P., Donnelly L.E., Pesci A., Kharitonov A., Barnes P.J. Increased nitrosothiols in exhaled breath condensate in inflammatory airway diseases. Am J Respir Crit Care Med. 163:2001;854-858.
66. Costello R.W., Evans C.M., Yost B.L., Belmonte K.E., Gleich G.J., Jacoby D.B., Fryer A.D. Antigen-induced hyperreactivity to histamine: role of the vagus nerves and eosinophils. Am J Physiol. 276:1999;L709-L714.
67. Cuthbertson B.H., Galley H.F., Webster N.R. Effect of inhaled nitric oxide on key mediators of the inflammatory response in patients with acute lung injury. Crit Care Med. 28:2000;1736-1741.
68. Daffonchio L., Payne A.N., Lees I.W., Whittle J.R. Airway hyperreactivity follows anaphylactic microshock in anesthetized guinea pigs. Eur J Pharmacol. 161:1989;135-142.
69. Danahay H., Broadley K.J. PDE4 inhibition and a corticosteroid in chronically antigen exposed conscious guinea pigs. Clin Exp Allergy. 28:1998;513-522.
70. De Boer J., Pouw F.M.H., Zaagsma J., Meurs H. Effects of endogenous superoxide anion and nitric oxide on cholinergic constriction of normal and hyperreactive guinea pig airways. Am J Respir Crit Care Med. 158:1998;1784-1789.
71. De Boer J., Duyvendak M., Schuurman F.E., Pouw F.M.H., Zaagsma J., Meurs H. Role of L-arginine in the deficiency of nitric oxide and airway hyperreactivity after the allergen-induced early asthmatic reaction in guinea pigs. Br J Pharmacol. 128:1999;1114-1120.
72. De Boer J., Meurs H., Flendrig L., Koopal M., Zaagsma J. Role of nitric oxide and superoxide in allergen-induced airway hyperreactivity after the late asthmatic reaction in guinea-pigs. Br J Pharmacol. 133:2001;1235-1242.
73. De Caterina R., Libby P., Peng H.B., Thannickal V.J., Rajavashisth T.B., Gimbrone M.A., Soo Shin W., Liao J.K. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest. 96:1995;60-68.
74. De Gouw H.W.F.M., Verbruggen M.B., Twiss I.M., Sterk P.J. Effects of oral L-arginine on airway hyperresponsiveness to histamine in asthma. Thorax. 54:1999;1033-1035.
75. Demiryurek A.T., Wadsworth R.M. Superoxide in the pulmonary circulation. Pharmacol Ther. 84:1999;355-365.
76. Denninger J.W., Marletta M.A. Guanylate cyclase and the NO/cGMP signalling pathway. Biochim Biopys Acta. 1411:1999;334-350.
77. De Raeve H.R., Thunnissen F.B., Kaneko F.T., Guo F.H., Lewis M., Kavuru M.S., Secic M., Thomassen M.J., Erzurum S.C. Decreased Cu,Zn-SOD activity in asthmatic airway epithelium: correction by inhaled corticosteroid in vivo. Am J Physiol. 272:1997;L148-L154.
78. De Sanctis G.T., MacLean J.A., Hamada K., Mehta S., Scott J.A., Jiao A., Yandava C.N., Kobzik L., Wolyniec W.W., Fabian A.J., Venugopal C.S., Grasemann H., Huang P.L., Drazen J.M. Contribution of nitric oxide synthases 1, 2, and 3 to airway hyperresponsiveness and inflammation in a murine model of asthma. J Exp Med. 189:1999;1621-1629.
79. Devillier P., Advenier C., Drapeau G., Marsac J., Regoli D. Comparison of the effects of epithelium removal and of enkephalinase inhibitor on the neurokinin-induced contractions of guinea-pig isolated trachea. Br J Pharmacol. 94:1988;675-684.
80. Deykin A., Halpern O., Massaro A.F., Drazen J.M., Israel E. Expired nitric oxide after bronchoprovocation and repeated spirometry in patients with asthma. Am J Respir Crit Care Med. 157:1998;769-775.
81. Dinh-Xuan A.T., Higenbottam T.W., Clelland C.A., Pepke-Zaba J., Cremona G., Butt A.Y., Large S.R., Well F.C., Wallwork J. Impairment of endothelium-dependent pulmonary-artery relaxation in chronic obstructive lung disease. N Eng J Med. 324:1991;1539-1547.
82. Dona G., Giuliani P.M., Cremonesi P., Passaro A., Stella P., Tursi F., Mizrahi J. Mechanism of ITF 296-induced vasorelaxation compared to nitroglycerin and isosorbide dinitrate: relationship between relaxation of rabbit aorta and tissue cGMP. J Cardiovasc Pharmacol. 26:1995;59-66.
83. Dotsch J.S., Demirakca H.G., Terbrack G., Huls W., Rascher W., Kuhl P.G. Airway nitric oxide in asthmatic children and patients with cystic fibrosis. Eur Respir J. 9:1996;2537-2540.
84. Duddridge M., Ward C., Hendrick D.J., Walters E.H. Changes in bronchoalveolar lavage inflammatory cells in asthmatic patients treated with high dose inhaled beclomethasone dipropionate. Eur Respir J. 6:1993;489-497.
85. Dupont L.J., Rochette F., Demedits M.G., Verleden G.M. Exhaled nitric oxide correlates with airway hyperresponsiveness in steroid-naïve patients with mild asthma. Am J Respir Crit Care Med. 157:1998;894-898.
86. Dupuy P.M., Shore S.A., Drazen J.M., Frostell C., Hill W.A., Zapol W.M. Bronchodilator action of inhaled nitric oxide in guinea pigs. J Clin Invest. 90:1992;421-428.
87. Dweik R.A., Comhair S.A.A., Gaston B., Thunnissen F.B.J.M., Farver C., Thomassen M.J., Kavuru M., Hammel J., Abu-Soud H.M., Erzurum S.C. NO chemical events in the human airway during the immediate and late antigen-induced asthmatic response. Proc Natl Acad Sci USA. 98:2001;2622-2627.
88. Eiserich J.P., Hristova M., Cross C.E., Jones A.D., Freeman B.A., Halliwell B., Van der Vilet A. Formation of nitric oxide-derived inflammatory oxidants by myelperoxidase in neutrophils. Nature. 391:1998;393-397.
89. Eiserich J.P., Estevez A.G., Bamberg T.V., Zu Ye Y., Chumley P.H., Beckman J.S., Freeman B.A. Microtubule dysfunction of posttranslational nitrotyrosination of α-tubulin: a nitric oxide-dependent mechanism of cellular injury. Proc Natl Acad Sci USA. 96:1999;6365-6370.
90. Ellis J.L. Inhibition by L-N-nitro-L-arginine of nonadrenergic-noncholinergic-mediated relaxations of human isolated central and peripheral airways. Am Rev Respir Dis. 146:1992;1543-1547.
91. Ellis J.L. Role of soluble guanyl cyclase in the relaxations to a nitric oxide donor and to nonadrenergic nerve stimulation in guinea pig trachea and human bronchus. J Pharmacol Exp Ther. 280:1997;1215-1218.
92. Ellis J.L., Conanan N.D. Effect of potassium channel blockers on relaxations to a nitric oxide donor and to nonadrenergic nerve stimulation in guinea pig trachea. J Pharmacol Exp Ther. 271:1994;782-786.
93. Ellis J.L., Conanan N.D. Modulation of relaxant responses evoked by a nitric oxide donor and by nonadrenergic, noncholinergic stimulation by isozyme-selective phosphodiesterase inhibitors in guinea pig trachea. J Pharmacol Exp Ther. 272:1994;997-1004.
94. Ellis J.L., Farmer S.G. The effects of vasoactive intestinal (VIP) antagonists, and VIP and peptide histidine isoleucine antisera on non-adrenergic, non-cholinergic relaxations of tracheal smooth muscle. Br J Pharmacol. 96:1989;513-520.
95. Ellis J.L., Farmer S.G. Effects of peptidases on non-adrenergic, non-cholinergic inhibitory responses of tracheal smooth muscle, a comparison with effects on VIP- and PHI-induced relaxation. Br J Pharmacol. 96:1989;521-526.
96. Elmer H.L., Brady K.G., Drumm M.L., Kelley T.J. Nitric oxide-mediated regulation of transepithelial sodium and chloride transport in murine nasal epithelium. Am J Physiol. 276:1999;L466-L473.
97. Erjefalt J.S., Ergefalt I., Sundler F., Persson C.G.A. Mucosal nitric oxide may tonically suppress airways plasma exudation. Am J Respir Crit Care Med. 150:1994;227-232.
98. Fang K., Johns R., MacDonald T., Kinter M., Gaston B. S-nitrosoglutathione breakdown prevents airway smooth muscle relaxation in the guinea pig. Am J Physiol. 23:2000;L716-L720.
99. Feder L.S., Stelts D., Chapman R.W., Manfra D., Crawley Y., Jones H., Minnicozzi M., Fernandez X., Paster T., Egan R.W., Kreutner W., Kung T.T. Role of nitric oxide on eosinophilic lung inflammation in allergic mice. Am J Respir Cell Mol Biol. 17:1997;436-442.
100. Feelisch M., Kelm M. Biotransformation of organic nitrates to nitric by vascular smooth muscle and endothelial cells. Biochem Biophys Res Commun. 180:1991;286-293.
101. Feelisch M., Noack E.A. Correlation between nitric oxide formation during degradation of organic nitrates and activation of guanylate cyclase. Eur J Pharmacol. 139:1987;19-30.
102. Feletou M., Lonchampt M., Coge F., Galizzi J.P., Bassoulet C., Merial C., Robineau P., Boutin J.A., Huang P.L., Vanhouette P.M., Canet E. Regulation of murine airway responsiveness by endothelial nitric oxide synthase. Am J Physiol. 281:2001;L258-L267.
103. Ferreira H.H.A., Medeiros M.V., Lima C.S.P., Flores C.A., Sannomiya P., Antunes E., De Nucci G. Inhibition of eosinophil chemotaxis by chronic blockade of nitric oxide biosynthesis. Eur J Pharmacol. 310:1996;201-207.
104. Ferreira H.H.A., Bevilacqua E., Gagioti S.M., De Luca I.M.S., Zanardo R.C.O., Teixeira C.E., Sannomiya P., Antunes E., De Nucci G. Nitric modulates eosinophil infiltration in antigen-induced airway inflammation in rats. Eur J Pharmacol. 358:1998;253-259.
105. Ferreira H.H.A., Martins A.R., Lodo M.L.S., Kandratavicius L., De Nucci G. Nitric oxide (NO) pathway in eosinophil from allergic rhinitis subjects. Inflamm Res. 50(suppl. 3):2001;S13.
106. 1 receptor. Br J Pharmacol. 117:1996;1270-1276.
107. Figini M., Ricciardolo L.M., Javdan P., Nijkamp F.P., Emanudeli C., Pradelles P., Folkerts G., Geppetti P. Evidence that epithelium-derived relaxing factor released by bradykinin in the guinea pig trachea is nitric oxide. Am J Respir Crit Care Med. 153:1996;918-923.
108. Filep J.G., Foldes-Filep E., Sirois P. Nitric oxide modulates vascular permeability in the rat coronary circulation. Br J Pharmacol. 108:1993;323-326.
109. Fischer A., Mundel P., Mayer B., Preissler U., Philippin B., Kummer W. Nitric oxide synthase in guinea pig lower airway innervation. Neurosci Lett. 149:1993;157-160.
110. Flak T.A., Goldman W.E. Autotoxicity of nitric oxide in airway disease. Am J Respir Crit Care Med. 154:1996;S202-S206.
111. Flavahan N.A., Slifman N.R., Gleich G.J., Vanhouette P.M. Human eosinophil major basic protein causes hyperreactivity of respiratory smooth muscle. Am Rev Respir Dis. 138:1988;685-688.
112. Folkerts G., Van der Linde H.J., Nijkamp F.P. Virus-induced airway hyperresponsiveness in guinea pigs is related to a deficiency in nitric oxide. J Clin Invest. 95:1995;26-30.
113. Forstermann U., Schmidt H.H.H.W., Pollock J.S., Sheng H., Mitchell J.A., Warner T.D., Nakane M., Murad F. Isoforms of nitric oxide synthase. Biochem Pharmacol. 42:1991;1849-1857.
114. Fox-Robichaud A., Payne D., Hasan S.U., Ostrovsky L., Fairhead T., Reinhardt P., Kubes P. Inhaled NO as a viable antiadhesive therapy for ischaemia/reperfusion injury of distal microvascular beds. J Clin Invest. 101:1998;2497-2505.
115. Furchgott R.F., Zawadzki J.V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 288:1980;373-376.
116. Gaboury J.P., Niu X.F., Kubes P. Nitric oxide inhibits numerous features of mast cell-induced inflammation. Circulation. 93:1996;318-326.
117. Garvey E.P., Oplinger J.A., Furfine E.S., Kiff R.J., Laszlo F., Whittle B.J.R., Knowles R.G. 1400W is a sow, tight binding and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo. J Biol Chem. 272:1997;4959-4963.
118. Gaston B. Nitric oxide and thiol groups. Biochim Biophys Acta. 1411:1999;323-333.
119. Gaston B., Reilly J., Drazen J.M., Fackler J., Ramdev P., Arnelle D., Mullins M.E., Sugabaker D.J., Chee C., Singel D.J., Loscalzo J., Stamler S. Endogenous nitrogen oxides and bronchodilator S-nitrosothiols in human airways. Proc Natl Acad Sci USA. 90:1993;10957-10961.
120. Gaston B., Drazen J.M., Jansen A., Sugarbaker D.A., Loscalzo J., Richards W., Stamler J.S. Relaxation of human bronchial smooth muscle by S-nitrosothiols in vitro. J Pharmacol Exp Ther. 268:1994;978-984.
121. Gaston B., Drazen J.M., Loscalzo J., Stamler J.S. The biology of nitrogen oxides in the airways. Am J Respir Cirt Care Med. 149:1994;538-551.
122. Gaston B., Sears S., Woods J., Hunt J., Ponaman M., McMahon T., Stamler J.S. Bronchodilator S-nitrosothiol deficiency in asthmatic respiratory failure. Lancet. 351:1998;1317-1319.
123. Gerlach H., Rossaint R., Pappert D., Knorr M., Falke K.J. Autoinhalation of nitric oxide after endogenous synthesis in nasopharynx. Lancet. 343:1994;518-519.
124. Gessler P., Nebe T., Birle A., Mueller W., Kachel W. A new side-effect of inhaled nitric oxide in neonates and infants with pulmonary hypertension: functional impairment of the neutrophil respiratory burst. Intensive Care Med. 22:1996;252-258.
125. Goldstein J.A. Nitroglycerin therapy of asthma. Chest. 85:1984;449.
126. Gomez F.P., Barbera J.A., Roca J., Iglesia R., Ribas J., Barnes P.J., Rodriguez-Roisin R. Effect of nitric oxide synthesis inhibition with nebulised L-NAME on ventilation-perfusion distributions in bronchial asthma. Eur Respir J. 12:1998;865-871.
127. Gourgoulianis K., Iliodromitis Z., Hatziefthimiou A., Molyvdas P.A. Epithelium-dependent regulation of airways smooth muscle function. A histamine-nitric oxide pathway. Mediators Inflamm. 7:1998;409-411.
128. Gow A.J., Thom S.R., Ischiropoulos H. Nitric oxide and peroxynitrite-mediated pulmonary cell death. Am J Physiol. 274:1998;L112-L118.
129. Granger D.L., Hibbs J.B. Jr., Perfect J.R., Durack D.T. Specific amino acid (L-arginine) requirement for the microbiostatic activity of murine macrophages. J Clin Invest. 81:1988;1129-1136.
130. Granger D.N., Kubes P. Nitric oxide as anti-inflammatory agent. Methods Enzymol. 269:1996;434-442.
131. Grasemann H., Ioannidis I., Tomkiewicz R.P., De Groot H., Rubin B.K., Ratjen F. Nitric oxide metabolites in cystic fibrosis lung disease. Arch Dis Child. 78:1998;49-53.
132. Grasemann H., Gartig S.S., Wiesmann H.G., Teschler H., Konietzko N., Ratjen F. Effect of L-arginine infusion on airway NO in cystic fibrosis and primary ciliary dyskinesia syndrome. Eur Respir J. 13:1999;114-118.
133. Grasemann H., Gaston B., Fang K., Paul K., Ratjen F. Decreased levels of nitrosothiols in the lower airways of patients with cystic fibrosis and normal pulmonary function. J Pediatr. 135:1999;770-772.
134. Green S.J., Nacy C.A., Meltzer M.S. Cytokine-induced synthesis of nitrogen oxides in macrophages: a protective host response to Leishmania and other intracellular pathogens. J Leuk Biol. 50:1991;93-103.
135. Grisham M.B., Jourd'heuil D., Wink D.A. Nitric oxide 1. Physiological chemistry of nitric oxide and its metabolites: implications in inflammation. Am J Physiol. 276:1999;G315-G321.
136. Gruetter C.A., Barry B.K., Gruetter P.J., Kadowitz P.J., Ignarro L.J. Recruitment of thiols for activation of coronary arterial guanylate cyclase by glyceryl trinitrate and sodium nitrite. Possible involvement of S-nitrosothiols. Biochim Biophys Acta. 631:1980;221-231.
137. Gruetter C.A., Barry B.K., McNamara D.B., Kadowitz P.J., Ignarro L.J. Coronary arterial relaxation and guanylate cyclase activation by cigarette smoke, N-nitrosonornicotine and nitric oxide. J Pharmacol Exp Ther. 214:1980;9-15.
138. Gruetter C.A., Edwin Childers C.E., Bosserman M.K., Lemke S.M., Ball J.G., Valentovic Mantovic M.A. Comparison of relaxation induced by glyceryl trinitrate, isosorbide dinitrate and sodium nitroprusside in bovine airways. Am Rev Respir Dis. 139:1989;1192-1197.
139. Guidot D.M., Repine M.J., Hybertson B.M., Repine J.E. Inhaled NO prevents neutrophil-mediated, oxygen radical-dependent leak in isolated lungs. Am J Physiol. 269:1995;L2-L5.
140. Guo F.H., De Raeve H.R., Rice T.W., Stuehr D.J., Thunnissen F.B.J.M., Erzurum S.C. Continuous nitric oxide synthesis by inducible nitric oxide synthase in normal human airway epithelium in vivo. Proc Natl Acad Sci USA. 92:1995;7809-7813.
141. Guo F.H., Comhair S.A.A., Zheng S., Dweik R.A., Eissa N.T., Thomassen M.J., Calhoun W., Erzuruum S.C. Molecular mechanisms of increased nitric oxide (NO) in asthma: evidence for transcriptional and post-translational regulation of NO synthesis. J Immunol. 164:2000;5970-5980.
142. 2-induced endothelial barrier dysfunction: mechanisms of protection. Am J Physiol. 280:2001;L116-L126.
143. Hamad A.M., Wisniewski A., Range S.P., Small T., Holland F., Knox A.J. The effect of the nitric oxide synthase inhibitor, L-NMMA, on sodium metabisulphite-induced bronchoconstriction and refractoriness in asthma. Eur Respir J. 14:1999;702-705.
144. Hamaguchi M., Ishibashi T., Imai S. Involvement of charybdotoxin-sensitive K channel in the relaxation of bovine tracheal smooth muscle by glyceryl trinitrate and sodium nitroprusside. J Pharmacol Exp Ther. 262:1992;263-271.
145. Hamid Q., Springall D.R., Riveros-Moreno V., Chanez P., Howarth P., Redington A., Bousquet J., Godard P., Holgate S., Polak J.M. Induction of nitric oxide synthase in asthma. Lancet. 342:1993;1510-1513.
146. Hammermann R., Hirchcann J., Hey C., Mossner J., Folkerts G., Nijkamp F.P., Wessler I., Racke K. Cationic proteins inhibit L-arginine uptake in rat alveolar macrophages and tracheal epithelial cells. Am J Respir Cell Mol Biol. 21:1999;155-162.
147. Hanazawa T., Kharitonov S.A., Barnes P.J. Increased nitrotyrosine in exhaled breath condensate of patients with asthma. Am J Respir Crit Care Med. 162:2000;1273-1276.
148. Hasan K., Heesen B.J., Corbett J.A., McDaniel M.L., Chang K., Allison W., Wolfenbuttel B.H.R., Williamson J.R., Tilton R.G. Inhibition of nitric oxide formation by guanidines. Eur J Pharmacol. 249:1993;101-106.
149. Hay D.W.P., Muccitelli R.M., Page C.P., Spina D. Correlation between airway epithelium-induced relaxation of rat aorta in the co-axial bioassay and cyclic nucleotide levels. Br J Pharmacol. 105:1992;954-958.
150. Heaslip R.J., Giesa F.R., Rimele T.J., Grimes D. Co-regulation of tracheal tone by cyclic AMP and cyclic GMP dependent mechanisms. J Pharmacol Exp Ther. 243:1987;1018-1026.
151. Heiss L.N., Lancaster J.R., Corbett J.A., Goldman W.E. Epithelial autotoxicity of nitric oxide: role in the respiratory cytopathology of pertussis. Proc Natl Acad Sci USA. 91:1994;267-270.
152. Henricks P.A.J., Nijkamp F.P. Reactive oxygen species as mediators in asthma. Pulm Pharmacol Ther. 14:2001;409-421.
153. Hernandez M., Elmedal B., Mulvany M.J., Simonsen U. Mechanisms of relaxations of bovine isolated bronchioles by the nitric oxide donor, GEA 3175. Br J Pharmacol. 123:1998;895-905.
154. Hibbs J.B. Jr., Taintor R.R., Vavrin Z. Macrophage cytotoxicity: role for L-arginine deiminase and imino nitrogen oxidation to nitrite. Science. 235:1987;473-477.
155. Hickey M.J., Sharkey D.A., Sihota E.G., Reinhardt P.H., Macmicking J.D., Nathan C., Kubes P. Inducible nitric oxide synthase-deficient mice have enhanced leukocyte-endothelium interactions in endotoxemia. FASEB J. 11:1997;955-964.
156. Hjoberg J., Hogman M., Hedenstierna G. Hyperosmolarity reduces the relaxing potency of nitric oxide donors in guinea-pig trachea. Br J Pharmacol. 127:1999;391-396.
157. Ho L.P., Innes J.A., Greening A.P. Nitrite levels in breath condensate of patients with cystic fibrosis is elevated in contrast to exhaled nitric oxide. Thorax. 53:1998;680-684.
158. Hogman M., Frostell C., Arnberg H., Hedenstierna G. Inhalation of nitric oxide modulates methacholine-induced bronchoconstriction in the rabbit. Eur Respir J. 6:1993;177-180.
159. Hogman M., Frostell C.G., Hedenstrom H., Henenstierna G. Inhalation of nitric oxide modulates adult human bronchial tone. Am Rev Respir Dis. 148:1993;1474-1478.
160. Hogman M., Hjoberg J., Hedenstierna G. Increased airway osmolarity inhibits the action of nitric oxide in the rabbit. Eur Respir J. 12:1998;1313-1317.
161. Holgate S.T. The cellular and mediator basis of asthma in relation to natural history. Lancet. 350:1997;5-9.
162. Holtzman M.J., Sheller J.R., DiMeo M., Nadel J.A., Boushey H.A. Effect of ganglionic blockade on bronchial reactivity in atopic subjects. Am Rev Respir Dis. 122:1980;17-25.
163. Horvath I., Donnelly L.E., Kiss A., Kharitonov S.A., Lim S., Chung K.F., Barnes P.J. Combined use of exhaled hydrogen peroxide and nitric oxide in monitoring asthma. Am J Respir Crit Care Med. 158:1998;1042-1046.
164. Hunt J., Gaston B. Airway nitrogen oxide measurements in asthma and other pediatric respiratory diseases. J Pediatr. 137:2000;14-20.
165. Hutchinson P.J.A., Palmer R.M.J., Moncada S. Comparative pharmacology of EDRF and nitric oxide on vascular strips. Eur J Pharmacol. 141:1987;445-451.
166. Ichinose M., Suigura H., Yamagata S., Koarai A., Shirato K. Increase in reactive nitrogen species production in chronic obstructive pulmonary disease airways. Am J Respir Crit Care Med. 162:2000;701-706.
167. Ignarro L.J., Gruetter C.A. Requirement of thiols for activation of coronary arterial guanylate cyclase by glyceryl trinitrate and sodium nitrate: possible involvement of S-nitrosothiois. Biochim Biophys Acta. 631:1980;221-231.
168. Ignarro L.J., Lippton H., Edwards J.C., Barico W.H., Hyman A.L., Kadowitz P.J., Gruetter C.A. Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. J Pharmacol Exp Ther. 218:1981;739-749.
169. Ignarro L., Byrns R.E., Wood K.S. Endothelium-dependent modulation of cGMP levels and intrinsic smooth muscle tone in isolated bovine intrapulmonary artery and vein. Circ Res. 60:1987;82-92.
170. Iijima H., Uchida Y., Endo T., Xiang A., Shirato M., Nomura A., Hasegawa S. Role of endogenous nitric oxide in allergen-induced airway responses in guinea pigs. Br J Pharmacol. 124:1998;1019-1028.
171. Iijima H., Duguet A., Eum S.Y., Hamid Q., Eidelman D.H. Nitric oxide and protein nitration are eosinophil dependent in allergen-challenged mice. Am J Respir Crit Care Med. 163:2001;1233-1240.
172. Ikuta N., Sugiyama S., Takagi K., Satake T., Ozawa T. Implication of oxygen radicals on airway hyperresponsiveness after ovalbumin challenge in guinea pigs. Am Rev Resp Dis. 145:1992;561-565.
173. Imasaki T., Kobayashi H., Hataishi R., Hayashi I., Tomita T., Majima M. Nitric oxide is generated in smooth muscle layer by neurokinin A and counteracts constriction in guinea pig airway. Nitric Oxide Biol Chem. 5:2001;465-474.
174. Irie-Sasaki J., Sasaki T., Matsumoto W., Opavsky A., Cheng M., Welstead G., Griffiths E., Krawczyk C., Richardson C.D., Aitken K., Iscove N., Koretzky G., Johnson P., Liu P., Rothstein D.M., Penninger J.M. CD45 is a JAK phosphatase and negatively regulates cytokine receptor signalling. Nature. 409:2001;349-354.
175. Ischiropoulos H. Biological tyrosine nitration: a pathophysiogical function of nitric oxide and reactive oxygen species. Arch Biochem Biophys. 356:1998;1-11.
176. Ishida K., Kelly L.J., Thomson R.J., Beatie L.L., Schellenberg R.R. Repeated antigen challenge induces airway hyperresponsiveness with tissue eosinophilia in guinea pigs. J Appl Physiol. 67:1989;1133-1139.
177. 1 receptor activation. Eur J Pharmacol. 331:1997;213-219.
178. Jain B., Rubinstein I., Robbins R.A., Leise K.L., Sisson J.H. Modulation of airway epithelial cell ciliary beat frequency by nitric oxide. Biochem Biophys Res Commun. 191:1993;83-88.
179. Jang A.S., Choi I.S., Lee S., Seo J.P., Yang S.W., Park K.O., Lee K.Y., Lee J.U., Park C.S., Park H.S. Nitric oxide metabolites in induced sputum: a marker of airway inflammation in asthmatic subjects. Clin Exp Allergy. 29:1999;1136-1142.
180. Jansen A., Drazen J., Osborne J.A., Brown R., Loscalzo J., Stamler J.S. The relaxant properties in guinea pig airways of S-nitrosothiols. J Pharmacol Exp Ther. 261:1992;154-160.
181. Jarjour N.N., Calhoun W.J. Enhanced production of oxygen radicals in asthma. J Lab Clin Med. 123:1994;131-137.
182. Jarjour N.N., Busse W.W., Calhoun W.J. Enhanced production of oxygen radicals in nocturnal asthma. Am Rev Respir Dis. 146:1992;905-911.
183. Jatakanon A., Lim S., Kharitonov S.A., Chung K.F., Barnes P.J. Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma. Thorax. 53:1998;91-95.
184. Jatakanon A., Kharitonov S., Lim S., Barnes P.J. Effect of differing doses of inhaled budesonide on markers of airway inflammation in patients with mild asthma. Thorax. 54:1999;108-114.
185. Jatakanon A., Lim S., Barnes P.J. Changes in sputum eosinophils predict loss of asthma control. Am J Respir Crit Care Med. 161:2000;64-72.
186. Jeong Y.G., Battigelli M.C., Bromberg P.A. Effects of glyceryl trinitrate on guinea pig trancheal smooth muscle. Am Rev Respir Dis. 117:1978;S133.
187. Johanningman J.A., Davis K., Miller S.L., Campbell R.S., Luchette F.A., Frame S.B., Branson R. Prone positioning and inhaled nitric oxide: synergistic therapies for acute respiratory distress syndrome. J Trauma. 50:2001;589-595.
188. Jones K.L., Hegab A.H., Hillman B.C., Simpson K.L., Jinkins P.A., Grisham M.B., Owens M.W., Sato E., Robbins R.A. Elevation of nitrotyrosine and nitrate concentrations in cystic fibrosis sputum. Pediatr Pulmonol. 30:2000;79-85.
189. Jones S.L., Kittelson J., Cowan J.O., Flannery E.M., Hancox R.J., McLachlan C.R., Taylor D.R. The predictive value of exhaled nitric oxide measurements in assessing changes in asthma control. Am J Respir Crit Care Med. 164:2001;738-743.
190. Jorens P.G., Van Overvel F.J., Bult H., Vetmeite P.A., Herman A. L-arginine-dependent production of nitrogen oxides by rat pulmonary macrophages. Eur J Pharmacol. 200:1991;205-209.
191. Kacmarek R.M., Ripple R., Cockrill A., Bloch K.J., Zapol W.M., Johnson D.C. Inhaled nitric oxide. A bronchodilator in mild asthmatics with methacholine-induced bronchospasm. Am J Respir Crit Care Med. 153:1996;128-135.
192. Kakuyama M., Ahluwalia A., Rodrigo J., Vallance P. Cholinergic contraction is altered in nNOS knockouts. Cooperative modulation of neural bronchoconstriction by nNOS and COX. Am J Respir Crit Care Med. 160:1999;2072-2078.
193. Kaminsky D.A., Mitchell J., Carroll N., James A., Soultanakis R., Janssen Y. Nitrotyrosine formation in the airways and lung parenchyma of patients with asthma. J Allergy Clin Immunol. 104:1999;747-754.
194. Kamosinka B., Radomski M.W., Duszyk M., Radomski A., Man S.F.P. Nitric oxide activates chloride currents in human lung epithelial cells. Am J Physiol. 272:1997;L1098-L1104.
195. Kanazawa H., Shoji S., Yoshikawa T., Hirata K., Yoshikawa J. Increased production of endogenous nitric oxide in patients with bronchial asthma and chronic obstructive pulmonary disease. Clin Exp Allergy. 28:1998;1244-1250.
196. Kanazawa H., Hirata K., Yoshikawa J. Possible mechanism of bronchoprotection by SIN-1 in anaesthetised guinea pigs: roles of nitric oxide and peroxynitrite. Clin Exp Allergy. 30:2000;445-450.
197. Kavanagh B.P., Mouchawar A., Goldsmith J., Pearl R.G. Effects of inhaled NO and inhibition of endogenous NO synthesis in oxidant-induced acute lung injury. J Appl Physiol. 76:1994;1324-1329.
198. Keatings V.M., Jatakanon A., Worsdell Y.M., Barnes P.J. Effects of inhaled and oral glucocorticosteroids on inflammatory indices in asthma and COPD. Am J Respir Crit Care Med. 155:1997;542-548.
199. Kelley T.J., Drumm M.L. Inducible nitric oxide synthase expression is reduced in cystic fibrosis murine and human airway epithelial cells. J Clin Invest. 102:1998;1200-1207.
200. Kennedy T., Summer W.R., Sylvester J., Robertson D. Airway response to sublingual nitroglycerin in acute asthma. JAMA. 246:1981;145-147.
201. Khan B.V., Harrison D.G., Olbrych M.T., Alexander W., Medford R.M. Nitric oxide regulates vascular cell adhesion molecule 1 gene expression and redox-sensitive transcriptional events in human vascular endothelial cells. Proc Natl Acad Sci USA. 93:1996;9114-9119.
202. Kharitonov S.A., Barnes P.J. State of the art: exhaled markers of pulmonary disease. Am J Respir Crit Care Med. 163:2001;1693-1722.
203. Kharitonov S.A., Yates D., Robbins R.A., Logan-Sinclair R., Shinebourne E.A., Barnes P.J. Increased nitric oxide in exhaled air of asthmatic patients. Lancet. 343:1994;133-135.
204. Kharitonov S.A., Lubec G., Lubec B., Hjelm M., Barnes P.J. L-Arginine increases exhaled nitric oxide in normal human subjects. Clin Sci. 88:1995;135-139.
205. Kharitonov S.A., O'Connor B.J., Evans D.J., Barnes P.J. Allergen-induced late asthmatic reactions are associated with elevation of exhaled nitric oxide. Am J Respir Crit Care Med. 151:1995;1894-1899.
206. Kharitonov S.A., Chung K.F., Evans D., O'Connor B.J., Barnes P.J. Increased exhaled nitric oxide in asthma is mainly derived from the lower respiratory tract. Am J Respir Crit Care Med. 153:1996;1773-1780.
207. Kharitonov S.A., Yates D.H., Barnes P.J. Inhaled glucocorticoids decrease nitric oxide in exhaled air of asthmatic patients. Am J Respir Crit Care Med. 153:1996;454-457.
208. Kharitonov S.A., Yates D.H., Chung K.F., Barnes P.J. Changes in the dose of inhaled steroid affect exhaled nitric oxide levels in asthmatic patients. Eur Respir J. 9:1996;196-201.
209. Kharitonov S.A., Sapienza M.M., Chung K.F., Barnes P.J. Prostaglandins mediate bradykinin-induced reduction of exhaled nitric oxide in asthma. Eur Respir J. 14:1999;1023-1027.
210. Khatri S.B., Ozkan M., McCarthy K., Laskowski D., Hammel J., Dweik R.A., Erzurium S.C. Alterations in exhaled gas profile during allergen-induced asthmatic reactions. Am J Respir Crit Care Med. 164:2001;1844-1848.
211. Kips J.C., Lefebvre R.A., Peleman R.A., Joos G.F., Pauwels R.A. The effect of a nitric oxide synthase inhibitor on the modulation of airway responsiveness in rats. Am J Respir Crit Care Med. 151:1995;1165-1169.
212. Koari A., Ichinose M., Sugiura H., Yamagata S., Hattori T., Shirato K. Allergic airway hyperresponsiveness and eosinophil infiltration is reduced by a selective iNOS inhibitor, 1400W, in mice. Pulm Pharmacol Ther. 13:2000;267-275.
213. Kolb H., Kolb-Bachofen V. Nitric oxide: a pathogenetic factor in autoimmunity. Immunol Today. 13:1992;157-160.
214. 2 peptide. Proc Natl Acad Sci USA. 93:1996;3377-3382.
215. Kontos H.A., Wei E.P., Mayhan W.G. Hydroxyl radical-dependent inactivation of guanylate cyclase in cerebral arterioles by methylene blue and LY83583. Stroke. 24:1993;427-434.
216. Kowaluk E.A., Fung H.L. Dissociation of nitrovasodilator-induced relaxation from cyclic GMP levels during in vitro nitrate tolerance. Eur J Pharmacol. 176:1990;91-95.
217. Kowaluk E.A., Fung H.L. Spontaneous liberation of nitric oxide cannot account for in vitro vascular relaxation by S-nitrosothiols. J Pharmacol Exp Ther. 255:1990;1256-1264.
218. Kreye V.A., Marquard E. Comparison of sodium nitroprusside and isoprenaline aerosols in histamine-induced bronchial asthma of the guinea pig. Naunyn Schmiedebergs Arch Pharmacol. 306:1979;203-207.
219. Kubes P. Nitric oxide modulates epithelial permeability in the feline small intestine. Am J Physiol. 262:1992;G1138-G1142.
220. Kubes P., Suzuki M., Granger D.N. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA. 88:1991;4651-4655.
221. Kubes P., Kanwar S., Niu X., Gaboury J.P. Nitric oxide synthesis inhibition induces leukocyte adhesion via superoxide and mast cells. FASEB J. 7:1993;1293-1299.
222. Kunz D., Walker G., Eberhardt W., Pfeilschifter J. Molecular mechanisms of dexamethasone inhibition of nitric oxide synthase expression in interleukin 1β-stimulated mesangial cells: evidence for the involvement of transcriptional and posttranslational regulation. Proc Natl Acad Sci USA. 93:1996;255-259.
223. Kuo H.P., Liu S., Barnes P.J. The effect of endogenous nitric oxide on neurogenic plasma exudation in guinea pig airways. Eur J Pharmacol. 221:1992;385-388.
224. Kuo H.P., Hwang H.C., Lin C.H., Wang H., Lu L.C. Effect of endogenous nitric oxide on tumour necrosis factor-α-induced leukosequestration and IL-8 release in guinea-pigs airways in vivo. Br J Pharmacol. 122:1997;103-111.
225. Kurose I., Kubes P., Wolf R., Anderson D.C., Paulson J., Miyasaka M., Granger D.N. Inhibition of nitric oxide production. Mechanisms of vascular albumin leakage. Circ Res. 73:1993;164-171.
226. Kurose I., Wolf R., Grisham M.B., Granger D.N. Modulation of ischaemia/reperfusion-induced microvascular dysfunction by nitric oxide. Circ Res. 74:1994;376-382.
227. Laszlo F., Whittle B.J.R., Evans S.M., Moncada S. Association of microvascular leakage with induction of nitric oxide synthase, effects of nitric oxide synthase inhibitors in various organs. Eur J Pharmacol. 283:1995;47-53.
228. Leeman M., Naeije R. Nitric oxide and hypoxic pulmonary hypertension. Eur Respir J. 8:1995;515-522.
229. Lefer D.J., Scalia R., Campbell B., Nossuli T., Hayward R., Salamon M., Grayson J., Lefer A.M. Peroxynitrite inhibits leukocyte-endothelial cell interactions and protects against ischemia-reperfusion injury in rats. J Clin Invest. 99:1997;684-691.
230. Leurs R., Bronzius M.M., Jansen W., Bast A., Timmerman H. Histamine H1-receptor-mediated cyclic GMP production in guinea pig lung tissue in an L-arginine-dependent process. Biochem Pharmacol. 42:1991;271-277.
231. Lewis C.A., Johnson A., Broadley K.J. Early and late phase bronchoconstrictions in conscious sensitized guinea-pigs after macro- and microshock inhalation of allergen and associated airway accumulation of leukocytes. Int J Immunopharmacol. 18:1996;415-422.
232. Li C.G., Rand M.J. Nitric oxide and vasoactive intestinal polypeptide mediate non-adrenergic, non-cholinergic inhibitory transmission to smooth muscle of the rat gastric fundus. Eur J Pharmacol. 191:1990;303-309.
233. Lim S., Jatakanon A., John M., Gilbey T., O'Connor B.J., Chung K.F., Barnes P.J. Effect of inhaled budesonide on lung function and airway inflammation. Assessment by various inflammatory markers in mild asthma. Am J. Respir Crit Care Med. 159:1999;22-30.
234. Lim S., Jatakanon A., Meah S., Oates T., Chung K.F., Barnes P.J. Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in mild to moderately severe asthma. Thorax. 55:2000;184-188.
235. Lim S., Tomita K., Carramori G., Jatakanon A., Oliver B., Keller A., Adcock I., Chung K.F., Barnes P.J. Low-dose theophylline reduces eosinophilic inflammation but not exhaled nitric oxide in mild asthma. Am J Respir Crit Care Med. 164:2001;273-276.
236. Lindeman K.S., Aryana A., Hirshman C.A. Direct effects of inhaled nitric oxide on canine peripheral airways. J Appl Physiol. 78:1995;1898-1903.
237. Lindsay G.W., Mahey R., Thompson D.C., Altiere R.J. Role of cGMP in mediating airway non-adrenergic non-cholinergic relaxation. Am J Respir Crit Care Med. 151:1995;A126.
238. Linnane S.J., Thin A.G., Keatings V.M., Moynihan J.B., McLoughlin P., Fitzgerald M.X. Glucocorticoid treatment reduces exhaled nitric oxide in cystic fibrosis patients. Eur Respir J. 17:2001;1267-1270.
239. Lipton S.A., Choi Y.B., Pan Z.H., Lei S.Z., Chen H.S.V., Sucher N.J., Loscalzo J., Singel D.J., Stamler J.S. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature. 364:1993;626-632.
240. Loskove J.A., Frishman W.H. Nitric oxide donors in the treatment of cardiovascular and pulmonary diseases. Am Heart J. 129:1995;604-613.
241. MacPherson J.C., Comhair S.A.A., Erzurum S.C., Klein D.F., Lipscomb M.F., Kavuru M.S., Samoszuk M.K., Hazen S.L. Eosinophils are a major source of nitric oxide-derived oxidants in severe asthma: characterization of pathways available to eosinophils for generating reactive nitrogen species. J Immunol. 166:2001;5763-5772.
242. Mahey R., Lindsay G.W., Thompson D.C., Altiere R.J. Relaxation of airway smooth muscle by sodium nitroprusside and nitric oxide are not correlated with increased cyclic GMP. Am J Respir Crit Care Med. 151:1995;A126.
243. Mann J.S., Cushley M.J., Holgate S.T. Adenosine-induced bronchoconstriction in asthma: role of parasympathetic stimulation and adrenergic inhibition. Am Rev Respir Dis. 132:1985;1-6.
244. Marin J., Rodriguez-Martinez M.A. Role of vascular nitric oxide in physiological and pathological conditions. Pharmacol Ther. 75:1997;111-134.
245. Marshall C., Mamary A.J., Verhoeven A.J., Marshall B.E. Pulmonary artery NADPH-oxidase is activated in hypoxic pulmonary vasoconstriction. Am J Respir Cell Mol Biol. 15:1996;633-644.
246. Marshall H.E., Stamler J.S. NO waiting to exhale in asthma. Am J Respir Crit Care Med. 161:2000;685-687.
247. Masaki Y., Munakata M., Ukita H., Homma Y., Kawakami Y. Nitric oxide (NO) can relax canine airway smooth muscle. Am Rev Respir Dis. 139:1989;A350.
248. Masini E., Mannaioni P.F., Pistelli A., Salvemini D., Vane J. Impairment of the L-arginine-nitric oxide pathway in mast cells from spontaneously hypertensive rats. Biochem Biophys Res Commun. 177:1991;1178-1182.
249. Massaro A.F., Gaston B., Kita D., Fanta C., Stamler J.S., Drazen J.M. Expired nitric oxide levels during treatment of acute asthma. Am J Respir Crit Care Med. 152:1995;800-803.
250. Massarro A.F., Mehta S., Lilly C.M., Kobzik L., Reilly J.J., Drazen J.M. Elevated nitric oxide concentrations in isolated lower airway gas of asthmatic subjects. Am J Respir Crit Care Med. 153:1996;1510-1514.
251. Mathews W.R., Kerr S.W. Biological activity of S-nitrosothiols: the role of nitric oxide. J Pharmacol Exp Ther. 267:1993;1529-1536.
252. Mattes J., Vans Gravesande K.S., Reining U., Alving K., Ihorst G., Henschen G., Kuehr J. NO in exhaled air is correlated with markers of eosinophilic airway inflammation in corticosteroid-dependent childhood asthma. Eur Respir J. 13:1999;1391-1395.
253. 2+-dependently converts L-arginine into an activator of soluble guanylyl cyclase. Biochem Biophys Res Commun. 164:1989;678-685.
254. Mayer B., Schrammel A., Klatt P., Koesling D., Schmidt K. Peroxynitrite-induced accumulation of cyclic GMP in endothelial cells and stimulation of purified soluble guanylyl cyclase. Dependence on glutathione and possible role of S-nitrosation. J Biol Chem. 270:1995;17355-19360.
255. Maziak W., Loukides S., Culpitt S., Sullivan P., Kharitonov S.A., Barnes P.J. Exhaled nitric oxide in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 157:1998;998-1002.
256. McCall T., Vallence P. Nitric oxide takes centre-stage with newly defined roles. Trends Pharmacol Sci. 13:1992;1-6.
257. McCall T.B., Palmer R.M., Moncada S. Induction of nitric oxide synthase in rat peritoneal neutrophils and its inhibition by dexamethasone. Eur J Immunol. 21:1991;2523-2527.
258. Mehta S., Drazen J.M., Lilly C.M. Endogenous nitric oxide and allergic bronchial hyperresponsiveness in guinea-pigs. Am J Physiol. 273:1997;L656-L662.
259. Mehta S., Lilly C.M., Rollenhagen J.E., Haley K.J., Asano K., Drazen J.M. Acute and chronic effects of allergic airway inflammation on pulmonary nitric oxide production. Am J Physiol. 272:1997;L124-L131.
260. Meltzer S., Goldberg B., Lad P., Easton J. Superoxide generation and its modulation by adenosine in the neutrophils of subjects with asthma. J Allergy Clin Immunol. 83:1989;960-966.
261. Meng Q., Springall D.R., Bishop A.E., Morgan K., Evans T.J., Habib S., Gruenert D.C., Gyi K.M., Hodson M.E., Yacoub M.H., Polak J.M. Lack of inducible nitric oxide synthase in bronchial epithelium: a possible mechanism of susceptibility to infection in cystic fibrosis. J Pathol. 184:1998;323-331.
262. Meurs H., Schuurman F.E., Duyvendak M., Zaagsma J. Deficiency of nitric oxide in polycation-induced airway hyperreactivity. Br J Pharmacol. 126:1999;559-562.
263. Mhanna M.J., Ferkol T., Martin R.J., Dreshaj I.A., Van Heeckeren A.M., Kelley T.J., Haxhiu M.A. Nitric oxide deficiency contributes to impairment of airway relaxation in cystic fibrosis mice. Am J Respir Cell Mol Biol. 24:2001;621-626.
264. Middelveld R.J.M., Alving K. Selective protective effects of nitric oxide inhalation on allergen-induced acute airway reactions in the pig. Clin Exp Allergy. 31:2001;1787-1795.
265. Middelveld R.J.M., Zetterquist W.C.G., Bergman D., Alving K.G. Nitric oxide synthase inhibition augments acute allergic reactions in the pig airways in vivo. Eur Respir J. 16:2000;836-844.
266. Miller W.C., Schultz T.F. Failure of nitroglycerin as a bronchodilator. Am Rev Respir Dis. 120:1979;471-472.
267. Misko T.P., Moore W.M., Katsen T.P., Nickols G.A., Corbett J.A., Tilton R.G., McDaniel M.L., Williamson J.R., Currie M.G. Selective inhibition of the inducible nitric oxide synthase by aminoguanidine. Eur J Pharmacol. 233:1993;119-125.
268. Miura M., Yamauchi H., Ichinose M., Ohuchi Y., Kageyama N., Tomaki M., Endoh N., Shirato K. Impairment of neural nitric oxide-mediated relaxation after antigen exposure in guinea pig airways in vitro. Am J Respir Crit Care Med. 156:1997;217-222.
269. Moilanen E., Vuorinen P., Kankaanranta H., Metsa-Ketela T., Vapaatalo H. Inhibition by nitric oxide-donors of human polymorphonuclear leucocyte function. Br J Pharmacol. 109:1993;852-858.
270. Moncada S., Higgs E.A. Endogenous nitric oxide: physiology, pathology and clinical relevance. Eur J Clin Invest. 21:1991;361-374.
271. Moncada S., Higgs A. Mechanisms of disease. The L-arginine-nitric oxide pathway. N Engl J Med. 329:1993;2002-2012.
272. Moncada S., Palmer R.M.J., Higgs E.A. Nitric oxide: physiology, pathophysiolgy, and pharmacology. Pharmacol Rev. 43:1991;109-142.
273. 6-(1-Iminoethyl)lysine: a selective inhibitor of inducible nitric oxide synthase. J Med Chem. 37:1994;3886-3888.
274. Morris S.Y., Billiar T.R. New insights into the regulation of inducible nitric oxide synthesis. Am J Physiol. 266:1994;E829-E839.
275. Motojima S., Frigas E., Loegering D.A., Gleich G.J. Toxicity of eosinophil cationic proteins for guinea pig tracheal epithelium in vitro. Am Rev Respir Dis. 139:1989;801-805.
276. Muijsers R.B.R., Folkerts G., Henricks P.A.J., Sadeghi-Hashjin G., Nijkamp F.P. Peroxynitrite: a two-faced metabolite of nitric oxide. Life Sci. 60:1997;1833-1845.
277. Muijsers R.B.R., van Ark I., Folkerts G., Koster A.S., van Oosterhout A.J.M., Postma D.S., Nijkamp F.P. Apocynin and 1400 W prevents airway hyperresponsiveness during allergic reactions in mice. Br J Pharmacol. 134:2001;434-440.
278. Myers P.R., Minor J.R., Guerra R., Bates J.N., Harrison D.G. Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrosocysteine than nitric oxide. Nature. 345:1990;161-163.
279. Nagaki M., Shimura S., Irokawa T., Sasaki T., Shirato K. Nitric oxide regulation of glycoconjugate secretion form feline and human airways in vitro. Respir Physiol. 102:1995;89-95.
280. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J. 6:1992;3051-3064.
281. Nathan C., Xie Q.W. Nitric oxide synthases: roles, tolls, and controls. Cell. 78:1994;915-918.
282. Nijkamp F.P., Van Der Line H.J., Folkerts G. Nitric oxide synthesis inhibitors induce airway hyperresponsiveness in the guinea pig in vivo and in vitro. Role of the epithelium. Am Rev Respir Dis. 148:1993;727-734.
283. Nogami H., Umeno E., Kano S., Hirose T., Nishima S. Effect of nitric oxide synthase inhibitor on allergen- and hyperventilation-induced bronchoconstriction in guinea-pigs. Eur Respir J. 12:1998;318-1321.
284. Oae S., Kim Y.H., Fukushima D., Shinhama K. New synthesis of thionitrites and their chemical reactivities. J Chem Soc Perkin Trans I. 1978;913-917.
285. Okayama M., Saaki H., Takishima T. Bronchodilator effect of sublingual isosorbide dinitrate in asthma. Eur J Clin Pharmacol. 26:1984;151-155.
286. Ollerenshaw S., Jarvis D., Woolcock M.D., Sullivan C., Scheibner T. Absence of immunoreactive vasoactive intestinal polypeptide in tissue from the lungs of patients with asthma. N Eng J Med. 320:1989;1244-1248.
287. Oswald I.P., Eltoum I., Wynn T.A., Schwartz B., Caspar P., Paulin D., Sher A., James S.L. Endothelial cells are activated by cytokine treatment to kill an intravascular parasite, Schistomosoma mansoni, through the production of nitric oxide. Proc Natl Acad Sci USA. 91:1994;999-1003.
288. Oury T.D., Day B.J., Crapo J.D. Extracellular superoxide dismutase: a regulator of nitric oxide bioavailability. Lab Invest. 75:1996;617-636.
289. Palmer R.M.J., Ferrige A.G., Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 327:1987;524-526.
290. Palmer R.M.J., Ashton D.S., Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature. 333:1988;664-666.
291. Payne D.N.R., Adcock I.M., Wilson N.M., Oates T., Scallan M., Bush A. Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in children with difficult asthma, after treatment with oral prednisolone. Am J Respir Crit Care Med. 164:2001;1376-1381.
292. Pepys J., Hutchcroft B.J. Bronchial provocation tests in etiologic diagnosis and analysis of asthma. Am Rev Respir Dis. 112:1975;829-859.
293. Persinger R.L., Blay W.M., Heintz N.H., Hemenway D.R., Janssen-Heininger Y.M.W. Nitrogen dioxide induces death in lung epithelial cells in a density-dependent manner. Am J Respir Cell Mol Biol. 24:2001;583-590.
294. Persson M.G., Gustafsson L.E. Allergen-induced airway obstruction in guinea pigs is associated with changes in nitric oxide levels in exhaled air. Acta Physiol Scand. 149:1993;461-466.
295. Persson M.G., Frierg S.G., Hedqvist P., Gustafsson L.E. Endogenous nitric oxide counteracts antigen-induced bronchoconstriction. Eur J Pharmacol. 249:1993;R7-R8.
296. Persson M.G., Wiklund N.P., Gustafsson L.E. Endogenous nitric oxide in single exhalations and the change during exercise. Am Rev Respir Dis. 148:1993;1210-1214.
297. Persson M.G., Zetterstrom O., Agrenius V., Ihre E., Gustafsson L.E. Single-breath nitric oxide measurements in asthmatic patients and smokers. Lancet. 343:1994;146-147.
298. Persson M.G., Friberg S.G., Lars E., Gustafsson L.E., Hedqvist P. The promotion of patient airways and inhibition of antigen-induced bronchial obstruction. Br J Pharmacol. 116:1995;2957-2962.
299. Piacentini G.L., Bodini A., Costella S., Vicentini L., Mazzi P., Suzuki Y., Peroni D., Boner A.L. Exhaled nitric oxide in asthmatic children exposed to relevant allergens: effect of flunisolone. Eur Respir J. 15:2000;730-734.
300. Pincus S.H., Di Napoli A.M., Schooley W.R. Superoxide production by eosinophils: activation by histamine. J Invest Dermatol. 79:1982;53-57.
301. Radi R., Beckman J.S., Bush K.M., Freeman B.A. Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide. Arch Biochem Biophys. 288:1991;481-487.
302. Radomski M.W., Palmer R.M.J., Moncada S. Glucorticosteroids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proc Natl Acad Sci USA. 87:1990;10043-10047.
303. Ramnarine S.I., Khawaja A.M., Barnes P.J., Rogers D.F. Nitric oxide inhibition of basal and neurogenic mucus secretion in ferret trachea in vitro. Br J Pharmacol. 118:1996;998-1002.
304. Ratjen F., Gartig S., Wiesemann H.G., Grasemann H. Effect of inhaled nitric oxide on pulmonary function in cystic fibrosis. Respir Med. 93:1999;579-583.
305. Raychaudhuri B., Dweik R., Connors M.J., Buhrow L., Malur A., Drazba J., Arroliga A.C., Erzurum S.C., Kavuru S., Thomassen M.J. Nitric oxide blocks nuclear factor-κB activation in alveolar macrophages. Am J Respir Crit Care Med. 21:1999;311-316.
306. Redington A.E., Meg Q.H., Springall D.R., Evans T.J., Creminon C., Maclouf J., Holgate S.T., Howarth J.P.H., Polak J.M. Increased expression of inducible nitric oxide synthase and cyclo-oxygenase-2 in the airway epithelium of asthmatic subjects and regulation by corticosteroid treatment. Thorax. 56:2001;335-336.
307. Rees D.D., Palmer R.M.J., Hodson H.F., Moncada S. A specific inhibitor of nitric oxide formation from L-arginine attenuates endothelium-dependent relaxation. Br J Pharmacol. 96:1989;418-424.
308. Rees D.D., Palmer R.M., Schulz R., Hodson H.F., Moncada S. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br J Pharmacol. 101:1990;746-752.
309. Ricciardolo F.L.M., Geppetti P., Mistretta A., Nadel J.A., Sapienza M.A., Bellofiore S., Di Maria G.U. Randomised double-blind placebo-controlled study of the effect of inhibition of nitric oxide synthesis in bradykinin-induced asthma. Lancet. 348:1996;374-377.
310. Ricciardolo F.L.M., Di Maria G.U., Mistretta A., Sapienza M.A., Geppetti P. Impairment of bronchoprotection by nitric oxide in severe asthma. Lancet. 350:1997;1297-1298.
311. Ricciardolo F.L.M., Vergnani L., Wiegand S., Ricci F., Manzoli N., Fischer A., Amadesi S., Fellin R., Geppetti P. Detection of nitric oxide release induced by a bradykinin in guinea-pig trachea and main bronchi using a porphyrinic microsensor. Am J Respir Cell Mol Biol. 22:2000;97-104.
312. Ricciardolo F.L.M., Timmers M.C., Geppetti P., Van Schadewijk A., Brahim J.J., Sont J.K., Heidi W., De Gouw F.M., Hiemstra P.S., Van Krieken J.H.J.M., Sterk P.J. Allergen-induced impairment of bronchoprotective nitric oxide synthesis in asthma. J Allergy Clin Immunol. 108:2001;198-204.
313. Richardson G., Benjamin N. Potential therapeutic uses for S-nitrosothiols. Clin Sci (Lond). 102:2002;99-105.
314. Robbins R.A., Hamel F.G., Floreani A.A., Gossman G.L., Nelson K.J., Belenky S., Rubinstein I. Bovine bronchial epithelial cells metabolise L-arginine to L-citrulline: possible role of nitric oxide synthase. Life Sci. 52:1993;709-716.
315. Robbins R.A., Barnes P.J., Springall D.R., Warren J.B., Kwon O.J., Buttery L.D.K., Wilson A.J., Geller D.A., Polak J.M. Expression of inducible nitric oxide in human lung epithelial cells. Biochem Biophys Res Commun. 203:1994;209-218.
316. Robbins R.A., Springall D.R., Warren J., Kwo O.J., Buttery L.D.K., Wilson A.J., Adcock I.M., Riversos-Moreno V., Moncada S., Polak J., Barnes P.J. Inducible nitric oxide synthase is increased in murine lung epithelial cells by cytokine stimulation. Biochem Biophys Res Commun. 198:1994;835-843.
317. + channels in cerebral artery smooth muscle cells. Am J Physiol. 265:1993;C299-C303.
318. Robinson D., Hamid Q., Bentley A., Ying S., Kay A.B., Durham S.R. Activation of CD4+ T cells, increased T(H2)-type cytokine mRNA expression and eosinophil recruitment in BAL after allergen inhalation challenge in patients with atopic asthma. J Allergy Clin Immunol. 92:1993;313-324.
319. 2-agonist-induced bronchodilatation in asthmatics. Pulm Pharmacol. 8:1995;137-141.
320. Rolla G., Bucca C., Brussino L. Effect of inhaled norepinephrine on the nitroglycerin induced bronchodilatation in asthmatics. Chest. 107:1995;169-172.
321. Rossaint R., Falke K.J., Lopez F., Slama K., Pison U., Zapol W. Inhaled nitric oxide for the adult respiratory distress syndrome. N Eng J Med. 328:1993;399-405.
322. Ruckes-Nilges C., Lindemann H., Klimek T., Glanz H., Weber W.M. Nitric oxide has no beneficial effects on ion transport defects in cystic fibrosis human nasal epithelium. Pflugers Arch. 441:2000;133-137.
323. Rydberg I.G.M.J., Andersson R.G.G., Grenegard M. Effects of the nitric oxide donor, GEA 3175, on guinea pig airways. Eur J Pharmacol. 329:1997;175-180.
324. Sadeghi Hashjin G., Folkerts G., Henricks P.A.J., Van de Loo P.G.F., Nijkamp F.P. Sodium nitroprusside induces relaxation of isolated guinea-pig trachea via a cyclic GMP-independent mechanism. Am J Respir Crit Care Med. 151:1995;A126.
325. Sadeghi-Hashjin G., Folkerts G., Henricks P.A., Verheyen A.K., Van Der Linde H.J., Van Ark I., Coene A., Nijkamp F.P. Peroxynitrite induces airway hyperresponsiveness in guinea pig in vitro and in vivo. Am J Respir Crit Care Med. 153:1996;1697-1701.
326. Sakuma I., Stuehr D.J., Gross S.S., Nathan C., Levi R. Identification of arginine as a precursor of endothelium-derived relaxing factor. Proc Natl Acad Sci USA. 85:1988;8664-8667.
327. Saleh D., Ernst P., Lim S., Barnes P.J., Glaid A. Increased formation of the potent oxidant peroxynitrite in the airways of asthmatic patients is associated with induction of nitric oxide synthase: effect of inhaled glucocorticoid. FASEB J. 12:1998;929-937.
328. Salome C.M., Roberts A.M., Brown N.J., Dermand J., Marks G.B., Woolcock A.J. Exhaled nitric oxide measurements in a population sample of young adults. Am J Respir Crit Care Med. 159:1999;911-916.
329. Salvemini D., Wang Z.Q., Zweier J.L., Samouilov A., Macarthur H., Misko T.P., Currie M.G., Cuzzocrea S., Sikorski J.A., Riley D.P. A nonpeptidyl mimic of superoxide dismutase with therapeutic activity in rats. Science. 286:1999;209-210.
330. Samb A., Pretolani M., Dinh-Xuan A.T., Ouksel H., Callebert J., Lisdero C., Aubier M., Boczkowski J. Decreased pulmonary and tracheal smooth muscle expression and activity of Type 1 nitric oxide synthase (nNOS) after ovalbumin challenge immunization and multiple aerosol challenge in guinea pigs. Am J Respir Crit Care Med. 164:2001;149-154.
331. Sanders S.A., Eisenthal R., Harrison R. NADH oxidase activity of human xanthine oxidoreductase:generation of superoxide anion. Eur J Biochem. 245:1997;541-548.
332. Sanders S.P. Asthma, viruses, and nitric oxide. Exp Biol Med. 220:1999;123-132.
333. Sanders S.P., Siekierski E.S., Porter J.D., Richards S.M., Proud D. Nitric oxide inhibits rhinovirus-induced cytokine production and viral replication in a human respiratory epithelial cell line. J Virol. 72:1998;934-942.
334. Sanjar S., Aoki S., Kristersson A., Smith D., Morley J. Antigen induces pulmonary airway eosinophil accumulation and airway hyperreactivity in sensitised guinea pigs: the effect of anti-asthma drugs. Br J Pharmacol. 99:1990;679-686.
335. Sapienza M.A., Kharitonov S.A., Horvath I., Chung K.F., Barnes P.J. Effect of inhaled L-arginine on exhaled nitric oxide in normal and asthmatic subjects. Thorax. 53:1998;172-175.
336. Sato E., Simpson K.L., Grisham M.B., Koyama S., Robbins R.A. Effects of reactive oxygen and nitrogen metabolites on eotaxin-induced eosinophil chemotactic activity in vitro. Am J Respir Cell Mol Biol. 22:2000;61-67.
337. Schlinder H., Bogdan C. Nitric oxide as a signalling molecule: effects on kinases. Int Immunopharmacol. 1:2001;1443-1455.
338. Schmidt H.H.W., Walter U. NO at work. Cell. 78:1994;919-925.
339. Schuiling M., Meurs H., Zuidhof A.B., Venema N., Zaagsma J. Dual action of iNOS-derived nitric oxide in allergen-induced airway hyperreactivity in conscious, unrestrained guinea pigs. Am J Respir Crit Care Med. 158:1998;1442-1449.
340. Schuiling M., Zuidhof A.B., Bonovrie M.A.A., Venema N., Zaagsma J., Meurs H. Role of nitric oxide in the development and partial reversal of allergen-induced airway hyperreactivity in conscious, unrestrained guinea pigs. Br J Pharmacol. 123:1998;1450-1456.
341. Sekizawa K., Fukushima T., Ikarashi Y., Maruyama Y., Sasaki H. The role of nitric oxide in cholinergic neurotransmission in rat trachea. Br J Pharmacol. 110:1993;816-820.
342. Sharara A.M., Hijazi M., Tarawneh M., Ind P.W. Nebulized glyceryl trinitrate exerts acute bronchodilator effects in patients with acute bronchial asthma. Pulm Pharmacol Ther. 11:1998;65-70.
343. Sheng H., Ishii K., Murad F. Generation of an endothelium-derived relaxing factor-like substance in bovine tracheal smooth muscle. Am J Physiol. 260:1991;L489-L493.
344. Silkoff P.E., Sylvester J.T., Zamel N., Permutt S. Airway nitric oxide diffusion in asthma. Role in pulmonary function and bronchial responsiveness. Am J Respir Crit Care Med. 161:2000;1218-1228.
345. Silvestri M., Sabatini F., Spallarossa D., Fregonese L., Battistini E., Biraghi M.G., Rossi G.A. Exhaled nitric oxide levels in non-allergic and allergic mono- or polysensitised children with asthma. Thorax. 56:2001;857-862.
346. Simpson A., Custovic A., Pipis S., Adisesh A., Faragher B., Woodcock W. Exhaled nitric oxide, sensitisation and exposure to allergens in patients with asthma who are not taking inhaled steroids. Am J Respir Crit Care Med. 160:1999;45-49.
347. Sippel J.M., Holden W.E., Tilles S.A., O'Hallaren M., Cook J., Thukkani N., Priest J., Nelson B., Osborne M.L. Exhaled nitric oxide levels correlate with measures of disease control in asthma. J Allergy Clin Immunol. 106:2000;645-650.
348. Small R.C., Good D.M., Dixon J.S., Kennedy I. The effects of epithelium removal on the actions of cholinomimetic drugs in opened segments and perfused tubular preparations of guinea-pig trachea. Br J Pharmcol. 100:1990;516-552.
349. Smith L.J., Houston M., Anderson J. Increased levels of glutathione in bronchoalveolar lavage fluid from patients with asthma. Am Rev Respir Dis. 147:1993;1461-1464.
350. Spruntulis L., Broadley K.J. Non-specific bronchial hyperresponsiveness, early and late asthmatic responses and cell influx in a conscious guinea pig model of asthma. Br Pharmacol. 126:1999;. 159P.
351. Stamler J.S., Jaraki O., Osborne J., Simon D.I., Keaney J., Vita J., Singel D., Valeri C.R., Loscalzo J. Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin. Proc Natl Acad Sci USA. 89:1992;7674-7677.
352. Stamler J.S., Simon D.I., Osborne J.A., Mullins M.E., Jaraki O., Michel T., Singel D., Loscalzo J. S-nitrosylation with nitric oxide: synthesis and characterization of biologically active compounds. Proc Natl Acad Sci USA. 89:1992;444-448.
353. Stamler J.S., Singel D.J., Loscalzo J. Biochemistry of nitric oxide and its redox-activated forms. Science. 258:1992;1898-1902.
354. Stirling R.G., Kharitonov S.A., Campbell D., Robinson D.S., Durham S.R., Chung K.F., Barnes P.J. Increase in exhaled nitric oxide levels in patients with difficult asthma and correlation with symptoms and disease severity despite treatment with oral and inhaled corticosteroids. Thorax. 53:1998;1030-1034.
355. Su Y., Couch M., Block E.R. Substrate inhibition of nitric oxide synthase in pulmonary artery endothelial cells in culture. Nitric Oxide. 1:1997;469-475.
356. Suigura H., Ichinose M., Oyake T., Mashito Y., Ohuchi Y., Encoh N., Miura M., Yamagata S., Koarai A., Akaike T., Maeda H., Shirato K. Role of peroxynitrite in airway microvascular hyperpermeability during late allergic phase in guinea pigs. Am J Respir Crit Care Med. 160:1999;663-671.
357. Takakura K., Beckman J.S., MacMillan-Crow L.A., Crow J.P. Rapid and irreversible inactivation of protein tyrosine phosphatases PTP1B, CD45 and LAR by peroxynitrite. Arch Biochem Biophys. 369:1999;197-207.
358. Takashi I., Miura M., Katsumata U., Ichinose M., Kimura K., Inoue H., Tadishima T., Shirato K. Involvement of superoxide in ozone-induced airway hyperresponsiveness in aneasthetized cats. Am Rev Respir Dis. 148:1993;103-106.
359. Tallet D., Del Soldato P., Burgaud J.L., Nicole O. Inhibition by NO-salbutamol and NO-budesonide of the bronchoconstriction by methacholine in guinea-pigs perfused brochioles. Inflamm Res. 50(suppl. 3):2001;S200.
360. Tamaoki J., Chiyotani A., Kondo M., Konno K. Role of NO generation in β-adrenoceptor-medicated stimulation of rabbit airway ciliary motility. Am J Physiol. 268:1995;C1342-C1347.
361. Taylor D.A., McGrath J.L., O'Connor B.J., Barnes P.J. Allegen-induced early and late asthmatic responses are not affected by inhibition of endogenous nitric oxide. Am J Respir Crit Care Med. 158:1998;99-106.
362. Taylor D.A., McGrath J.L., Orr L.M., Barnes P.J., O'Connor B.J. Effect of endogenous nitric oxide inhibition on airway responsiveness to histamine and adenosine-5-monophosphate in asthma. Thorax. 53:1998;483-489.
363. Terada A., Fujisawa T., Togashi K., Miyazaki T., Katsumata H., Atsuta J., Iguchi K., Kamiya H., Togari H. Exhaled nitric oxide decreases during exercise-induced bronchoconstriction in children with asthma. Am J Respir Crit Care Med. 164:2001;1879-1884.
364. Thomas S.R., Kharitonov S.A., Scott S.F., Hodson M.E., Barnes P.J. Nasal and exhaled nitric oxide is reduced in adult patients with cystic fibrosis and does not correlate with cystic fibrosis genotype. Chest. 117:2000;1085-1089.
365. Thomassen M.J., Raychaudhuri B., Dweik R.A., Farver C., Buhrow L., Malur A., Connors M.J., Drazba J., Hammel J., Erzurum S.C., Kavuru M.S. Nitric oxide regulation of asthmatic airway inflammation with segmental allergen challenge. J Allergy Clin Immunol. 104:1999;1174-1182.
366. Toward T.J., Broadley K.J. Airway reactivity, inflammatory cell influx and nitric oxide in guinea pig airways after lipopolysaccharide inhalation. Br J Pharmacol. 131:2000;271-281.
367. Toward T.J., Lewis-Lakelin M.B., Burgaud J.-L., Broadley K.J. Comparison of the inhibition by salbutamol-NO and salbutamol of the bronchoconstriction by histamine in conscious guinea-pigs. Inflamm Res. 50(suppl. 3):2001;S181.
368. Trifilieff A., Fujitani Y., Mentz F., Dugas B., Fuentes M., Bertrand C. Inducible nitric oxide synthase inhibitors suppress airway inflammation in mice through down-regulation of chemokine expression. J Immunol. 165:2000;1526-1533.
369. Trujillo M., Alvarez M.N., Peluffo G., Freeman B.A., Radi R. Xanthine oxidase-mediated decomposition of S-nitrosothiols. J Biol Chem. 273:1998;7828-7834.
370. Tucker J.F., Brave S.R., Charalambous L., Hobbs A.J., Gibson A. L-N-nitro arginine inhibits non-adrenergic, non-cholinergic relaxations of guinea pig isolated tracheal smooth muscle. Br J Pharmacol. 100:1990;663-664.
371. Tulie M.K., Wale J.L., Holt P.G., Sly P.D. Differential effects of nitric oxide synthase inhibitors in an in vivo allergic rat model. Eur Respir J. 15:2000;870-877.
372. Vaali K., Li L., Redemann B., Paakkari I., Vapaatalo H. In-vitro bronchorelaxing effects of novel nitric oxide donors GEA 3268 and GEA 5145 in guinea pigs and rats. J Pharm Pharmacol. 48:1996;1309-1314.
373. Vaali K., Li L., Pakkari I., Vapaatalo H. Relaxing effects of NO donors on guinea pig trachea in vitro are mediated by calcium-sensitive potassium channels. J Pharmacol Exp Ther. 286:1998;110-114.
374. Valentovic M.A., Ball J.G., Morenas M., Szarek J.L., Gruetter C.A. Influence of nitrovasodilators on bovine pulmonary histamine release. Pulm Pharmacol. 5:1992;97-102.
375. Van der Vilet A., Eiserich J.P., Shigenaga M.K., Cross C.E. Reactive nitrogen species and tyrosine nitration in the respiratory tract. Am J Respir Crit Care Med. 160:1999;1-9.
376. Van Rensen E.L.J., Straathof K.C.M., Veselic-Charvat M.A., Zwinderman A.H., Bel E.H., Sterk P.J. Effect of inhaled steroids on airway hyperresponsiveness, sputum eosinophils and exhaled nitric oxide levels in patients with asthma. Thorax. 54:1999;403-408.
377. Villain M., Jackson P.L., Manion M.K., Dong W.J., Su Z., Fassina G., Johnson T.M., Sakai T.T., Krishna N.R., Blalock J.E. De novo design of peptides targeted to the EF hands of calmodulin. J Biol Chem. 275:2000;2676-2685.
378. Vrugt B., Aalbers R. Inflammation and bronchial hyperresponsiveness in allergic asthma and chronic obstructive pulmonary disease. Respir Med. 87:1993;3-7.
379. Wanikiat P., Woodward D.F., Armstrong R.A. Investigation of the role of nitric oxide and cyclic GMP in both the activation and inhibition of human neutrophils. Br J Pharmacol. 122:1997;1135-1145.
380. Wanstall J.C., Hughes I.E., O'Donnell S.R. Evidence that nitric oxide from the endothelium attenuates inherent tone in isolated pulmonary arteries from rats with hypoxic pulmonary hypertension. Br J Pharmacol. 114:1995;109-114.
381. Ward J.K., Fox A.J., Miura M., Tadjkarimi S., Yacoub M.H., Barnes P.J., Belvisi M.G. Modulation of cholinergic neurotransmission by nitric oxide in human airway smooth muscle. Br J Pharmacol. 107:1992;. 85P.
382. Wardlaw A.J., Dunette S., Gleich G.J., Collins J.V., Kay A.B. Eosinophils and mast cells in the BAL in subjects with mild asthma. Relationship to bronchial hyperreactivity. Am Rev Respir Dis. 137:1988;62-69.
383. Wei X., Charles I.G., Smith A., Ure J., Feng G., Huang F., Xu S., Muller W., Moncada S., Liew F.Y. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature. 375:1995;408-411.
384. Wizemann T.M., Gardner C.R., Laskin J.D., Quinones S., Durham S.K., Goller N.L., Ohnishi T., Laskin D.L. Production of nitric oxide and peroxynitrite in the lung during acute endotoxemia. J Leukoc Biol. 56:1994;759-768.
385. Wolin M.S., Cherry P.D., Rodenburg J.M., Messina E.J., Kaley G. Methylene blue inhibits vasodilation of skeletal muscle to acetylcholine and nitric oxide via the extracellular generation of superoxide anion. J Pharmacol Exp Ther. 254:1990;872-876.
386. Woschnagg C., Rak S., Venge P. Oxygen radical production by blood eosinophils is reduced during birch pollen season in allergic patients. Clin Exp Allergy. 26:1996;1064-1072.
387. Wu M., Pritchard K.A., Kaminski P.M., Fayngersh R.P., Hintze T.H., Wolin M.S. Involvement of nitric oxide and nitrosothiols in relaxation of pulmonary arteries to peroxynitrite. Am J Physiol. 266:1994;H2108-H2113.
388. Wu W., Chen Y., Hazen S.L. Eosinophil peroxidase nitrates protein tyrosyl residues. Implications for oxidative damage by nitrating intermediates in eosinophilic inflammatory disorders. J Biol Chem. 274:1999;25933-25944.
389. Xia Y., Dawson V.L., Dawson T.M., Synyder S.H., Zweier J.L. Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury. Proc Natl Acad Sci USA. 93:1996;6770-6774.
390. Xiong Y., Karupiah G., Hogan S.P., Foster P.S., Ramsay A.J. Inhibition of allergic airway inflammation in mice lacking nitric oxide synthase 2. J Immunol. 162:1999;445-452.
391. Yates D.H. Role of exhaled nitric oxide in asthma. Role of exhaled nitric oxide in asthma. Immunol Cell Biol. 79:2001;178-190.
392. Yates D.H., Kharitonov S.A., Thomas P.S., Barnes P.J. Endogenous nitric oxide is decreased in asthmatic patients by an inhibitor of inducible nitric oxide synthase. Am Rev Resp Crit Care Med. 154:1996;247-250.
393. Yoshihara S., Nadel J.A., Figini M., Emanueli C., Pradelles P., Geppetti P. Endogenous nitric oxide inhibits broncoconstriction induced by cold-air inhalation in guinea pigs. Role of kinins. Am J Respir Crit Care Med. 157:1998;547-552.
394. Zanardo R.C.O., Costa E., Ferreira H.H.A., Antunes E., Martins A.R., Murad F., De Nucci G. Pharmacological and immunohistochemical evidence for a functional nitric oxide synthase system in rat peritoneal eosinophils. Proc Natl Acad Sci USA. 94:1997;14111-14114.
395. Zhou H.L., Torphy T.J. Relationship between cyclic guanosine monophosphate accumulation and relaxation of canine trachealis induced by nitrovasodilators. J Pharmac Exp Ther. 258:1991;972-978.